Correlation Between Jacobs Solutions and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Jacobs Solutions and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jacobs Solutions and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jacobs Solutions and Aquestive Therapeutics, you can compare the effects of market volatilities on Jacobs Solutions and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jacobs Solutions with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jacobs Solutions and Aquestive Therapeutics.
Diversification Opportunities for Jacobs Solutions and Aquestive Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Jacobs and Aquestive is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Jacobs Solutions and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Jacobs Solutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jacobs Solutions are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Jacobs Solutions i.e., Jacobs Solutions and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Jacobs Solutions and Aquestive Therapeutics
Taking into account the 90-day investment horizon Jacobs Solutions is expected to generate 3.87 times less return on investment than Aquestive Therapeutics. But when comparing it to its historical volatility, Jacobs Solutions is 3.94 times less risky than Aquestive Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 215.00 in Aquestive Therapeutics on September 2, 2024 and sell it today you would earn a total of 294.00 from holding Aquestive Therapeutics or generate 136.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Jacobs Solutions vs. Aquestive Therapeutics
Performance |
Timeline |
Jacobs Solutions |
Aquestive Therapeutics |
Jacobs Solutions and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Jacobs Solutions and Aquestive Therapeutics
The main advantage of trading using opposite Jacobs Solutions and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jacobs Solutions position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.Jacobs Solutions vs. KBR Inc | Jacobs Solutions vs. Tetra Tech | Jacobs Solutions vs. Fluor | Jacobs Solutions vs. Topbuild Corp |
Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |